Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/9217
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | L. Diaz, Bruno | - |
dc.contributor.author | Bandeira-Melo, Christianne | - |
dc.date.accessioned | 2024-12-18T03:09:51Z | - |
dc.date.available | 2024-12-18T03:09:51Z | - |
dc.date.issued | 2024 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/9217 | - |
dc.description.abstract | Prostaglandin (PG)D2 is produced and/or triggered by different parasites to modulate the course of the infection. These findings position PGD2 as a therapeutic target and suggest potential beneficial effects of repositioned drugs that target its synthesis or receptor engagement. However, recent in vivo data may suggest a more nuanced role and warrants further investigation of the role of PGD2 during the full course and complexity of parasitic infections | en_US |
dc.title | Parasitic infections: A new frontier for PGD2 functions | en_US |
dc.type | Article | en_US |
Appears in Collections: | VOL 5 2024 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
100077.pdf | 8.36 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.